This study is looking at whether using 0.05% Chlorhexidine Gluconate (CGH) bladder instillations can help patients with long-term suprapubic catheters (a tube placed into the bladder through the belly) who often get urinary tract infections (UTIs). The main goals are to see if these instillations are easy to do in an outpatient setting and if patients can tolerate them well. Researchers also want to find out if this treatment can reduce unplanned hospital visits and improve your quality of life. You might be able to join if you are 18 or older, have had a suprapubic catheter for at least a year, and have had UTIs in the past six months. The study is currently recruiting 70 participants.

Study design

This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 70 participants.

What's involved

You would receive bladder instillations during your routine suprapubic catheter exchanges for 9 months (3 months of saline followed by 6 months of chlorhexidine gluconate).

Compensation

Not stated in the trial record.

Follow-up

The primary endpoints for tolerability and feasibility are measured at 9 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.